Raymond James Financial’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.11M Buy
30,432
+9,295
+44% +$338K ﹤0.01% 3499
2025
Q1
$765K Sell
21,137
-637
-3% -$23.1K ﹤0.01% 3655
2024
Q4
$916K Buy
+21,774
New +$916K ﹤0.01% 3495